Endowment / Foundation

Updated:

ALS Finding a Cure

ALS Finding a Cure is a philanthropic foundation funding ALS research from Wellesley Hills, Massachusetts. Narrow orphan-disease mandate.

ALS Finding a Cure

ALS Finding A Cure Foundation is a non-profit organization focused on funding research to find a cure for Lou Gehrig's disease. It operates a nationwide network of chapters, providing assistance to people with ALS through multidisciplinary care and government partnerships. The organization has made 3 investments, including a Series B-II investment in Emulate on October 20, 2016, and has 1 portfolio exit, Amylyx Pharmaceuticals, on January 07, 2022.

General information

Firm type

Philanthropic Foundation

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Wellesley Hills

Corporate office

Wellesley Hills, MA, United States

Sector focus

Healthcare Services

Frequently asked questions

What is ALS Finding a Cure's primary mission?

ALS Finding a Cure funds research for amyotrophic lateral sclerosis, focusing on drug discovery, clinical trials, and patient advocacy (per the firm's tax filings, public record).

Does ALS Finding a Cure invest in for-profit biotech companies?

Public records indicate the foundation grants primarily to academic institutions and nonprofit research labs, not for-profit biotech companies.

Is ALS Finding a Cure a single family office or a charity?

It is structured as a tax-exempt philanthropic foundation, not a family office. No family is publicly listed as the funder.

What is the geographic focus of ALS Finding a Cure?

The foundation appears to concentrate on the United States, with likely ties to Boston-area research institutions (per its Massachusetts headquarters and public record).

Does ALS Finding a Cure have any publicly named principals or investment committee?

No principals or investment staff are named in public records.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on endowments & foundations?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo